Switch expensive in-chair whitening for Aussies favourite at-home kit: SmilePro
There's no better confidence boost than a gleaming white smile.
If you're ready to kickstart your teeth-whitening journey but not willing to splash cash on an expensive in-chair appointment at the dentist, we have just the solution for you.
Meet SmilePro, Australia's number one at-home teeth whitening solution, trusted by over 500,000 Aussies.
With rave reviews, shoppers say the best-selling whitening kit delivers visible results in 'just one use,' for just $3.50 per treatment with no sensitivity, no discomfort, and no hefty price tag.
Best yet, you can score 50 per cent off the sought-after range.
For a limited-time only, pick up the award-winning SmilePro Advanced Whitening Kit that uses dual-action LED technology, for just $104.50.
The blue light accelerates the whitening formula, targeting deep stains from coffee, wine, soda, and smoking, while the red light focuses on supporting gum health, reducing inflammation, and eliminating bad-breath-causing bacteria.
This innovative combination ensures not only a brighter smile but also improved oral health in just 10 minutes a day.
Each kit comes with 30 treatments, and users can expect up to eight shades whiter teeth in as little as one day.
What makes SmilePro even more appealing is its simplicity.
There are no messy strips, no enamel damage, no sensitivity, and certainly no awkward trips to the dentist. It's no surprise that SmilePro's Advanced Whitening Kit has earned the title of Australia's number one whitening kit, offering dentist-quality results at a fraction of the cost.
The product's popularity is not just among everyday users; it has become a favourite among beauty experts and Australian celebrities.
Personalities like Elly Miles, Jessika Power, and Ali Oetjen all swear by SmilePro for their red carpet-ready smiles. Whether they're prepping for a special event or simply upgrading their self-care routine, these influencers and celebrities trust SmilePro to deliver reliable, stunning results.
SmilePro's mission to make teeth whitening accessible to everyone began as a passion project, and it's now a leading force in the industry.
The latest version of the Advanced Whitening Kit features a newly designed mouthpiece equipped with blue and red LED lights, offering faster results and better oral health in just minutes.
The formula is enamel-safe and sensitivity-free, designed to tackle everything from everyday stains to the more stubborn ones caused by coffee or wine.
What sets SmilePro apart is its commitment to customer satisfaction and innovation. With a 30-day satisfaction guarantee and a founder-led approach that focuses on transparency and trust, SmilePro continues to exceed expectations.
It's no longer just a teeth-whitening kit; it's a complete oral care solution trusted by hundreds of thousands of users.
Shoppers are obsessed with the advanced teeth whitening kit and have left glowing reviews on SmilePro's website.
'Absolutely love it, great results,' one shopper wrote.
'Amazing product! Noticed instant results after the first use! Have recommended SmilePro to all my friends and have had comments about how white my teeth look,' another shopper added.
'I have tried a number of different teeth whitening kits throughout the years and I have to say that SmilePro is the only product that shows results the first time you use it! So stoked!' A third person commented.
Shop more teeth whitening products:
If you prefer to white your teeth on-the-go, then SmilePro also has a Whitening Pen Pack which retails for $40 and includes three whitening pens.
Another great option to maintain your white teeth is SmilePro's whitening toothpaste which retails for $16 and has antibacterial properties.
SmilePro also sells Whitening Strips for $45 which will help you achieve whiter teeth in just thirty minutes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
9 News
8 hours ago
- 9 News
Revolutionary late-stage melanoma treatment sees survival rates surge
Your web browser is no longer supported. To improve your experience update it here A revolution in the treatment of late-stage melanoma has been reached, with clinical trial results seeing surging survival rates. Doctors are confident the new therapy approach, which will be subsidised by the Pharmaceutical Benefits Scheme (PBS), will overhaul the treatment of many types of deadly cancers. A tumour the size of a golf ball saw death come knocking for Matthew Croxford. A revolution in the treatment of late-stage melanoma has been reached with clinical trial results seeing surging survival rates (Nine) "You think - is this it?" the 52-year-old father-of-two told 9News. "And I had a lot of things to still achieve in my life." Croxford was offered to take part in an Australian and Netherlands-driven trial. The new therapy has flipped the cancer paradigm on its head, by giving the body the best opportunity to activate its own cancer-fighting defences. "It's like the sniffer dogs that find the fruit and veg and drugs at the airport, they're trained against what they need to find," The Melanoma Institute's Professor Georgina Long said. "By giving immunotherapy before surgery, we train our immune system better against the cancer," she said. A new therapy has flipped the cancer paradigm on its head by giving the body the best opportunity to activate its own cancer-fighting defences. (Nine) Of the 423 patients with Stage 3 melanoma, one group received usual treatment with surgery first, then a single immunotherapy drug. That order was then flipped for the other group, who were given two immunotherapy drugs first to shrink the tumour before surgery. "Their chance of the melanoma coming back is next to zero - it's less than five per cent," Long said. Such revolutionary results have seen the treatment approved to be funded by the PBS - a world first. Matthew Croxford was offered to take part in an Australian and Netherlands-driven trial. (Nine) Australia has the highest rates of melanoma in the world, with one person diagnosed every 30 minutes and a life lost every six hours because of the disease. Advances in treatment like this shift a diagnosis that has often been a death sentence to promising odds of survival. "I'm effectively cancer-free, I have no side effects whatsoever, and I'm incredibly fortunate," Croxford said. "It's like the sniffer dogs that find the fruit and veg and drugs at the airport, they're trained against what they need to find," The Melanoma Institute's Professor Georgina Long said. (Nine) The radical overhaul of traditional treatment is now being explored for other cancers, including lung, triple-negative breast cancer, kidney, head and neck cancers. This new treatment for Stage 3 melanoma patients is to be listed on the PBS within months. national cancer health melanoma medicine PBS CONTACT US Property News: The last inner Sydney suburbs where houses cost under $2m.
Sydney Morning Herald
9 hours ago
- Sydney Morning Herald
‘A bomb thrown into the middle of science': Trump cuts hurt Australian medical research
Australian medical research institutes are suspending projects on malaria, tuberculosis and women's health, as well as laying off staff, as they reel from the Trump administration's multibillion-dollar science cuts. The situation has drawn condemnation from Australian scientists. Burnet Institute director Professor Brendan Crabb likened the cuts to 'having a bomb thrown into the middle of science'. 'The world of science and research in all its forms … is undergoing a global seismic shift as a result of what the US is doing,' he said. 'I can't think of another circumstance since the end of World War II where things have been upended so profoundly.' Preliminary estimates from the Burnet Institute show that the US cuts have left a $1.2 million funding shortfall across the organisation's global health programs and collaborations. A spokeswoman said this had led to the suspension until 2030 of research projects involving malaria, harm reduction, tuberculosis and women's and children's health. Loading Professor James Beeson, a world-renowned malaria researcher from the Burnet Institute, said the cuts would put millions of lives at risk. Beeson pointed to research by the Malaria Atlas Project, which estimates that a complete freeze in US funding would lead to 15 million additional cases of malaria every year and 107,000 deaths. Maternal deaths, stillbirths, tuberculosis and HIV rates throughout the Asia-Pacific region and parts of Africa would also increase substantially over the next few years unless the funding cuts were reversed or replaced by other funding sources, he said.
The Age
9 hours ago
- The Age
‘A bomb thrown into the middle of science': Trump cuts hurt Australian medical research
Australian medical research institutes are suspending projects on malaria, tuberculosis and women's health, as well as laying off staff, as they reel from the Trump administration's multibillion-dollar science cuts. The situation has drawn condemnation from Australian scientists. Burnet Institute director Professor Brendan Crabb likened the cuts to 'having a bomb thrown into the middle of science'. 'The world of science and research in all its forms … is undergoing a global seismic shift as a result of what the US is doing,' he said. 'I can't think of another circumstance since the end of World War II where things have been upended so profoundly.' Preliminary estimates from the Burnet Institute show that the US cuts have left a $1.2 million funding shortfall across the organisation's global health programs and collaborations. A spokeswoman said this had led to the suspension until 2030 of research projects involving malaria, harm reduction, tuberculosis and women's and children's health. Loading Professor James Beeson, a world-renowned malaria researcher from the Burnet Institute, said the cuts would put millions of lives at risk. Beeson pointed to research by the Malaria Atlas Project, which estimates that a complete freeze in US funding would lead to 15 million additional cases of malaria every year and 107,000 deaths. Maternal deaths, stillbirths, tuberculosis and HIV rates throughout the Asia-Pacific region and parts of Africa would also increase substantially over the next few years unless the funding cuts were reversed or replaced by other funding sources, he said.
